Clinical Trials Logo

PTSD clinical trials

View clinical trials related to PTSD.

Filter by:

NCT ID: NCT01678196 Active, not recruiting - PTSD Clinical Trials

Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT

Start date: May 2013
Phase: N/A
Study type: Interventional

This project begins to evaluate the effectiveness of a web-based family outreach tool that is designed to promote treatment engagement among Veterans with posttraumatic stress disorder (PTSD) or alcohol use disorders (AUDs) but who have not yet engaged in mental health care. The National Center for PTSD has developed an on-line, Veteran-tailored, interactive web tool called VA - Community Reinforcement and Family Training (VA-CRAFT) that trains family members to effectively help their Veterans to engage in treatment for PTSD and/or AUDs. This project will provide preliminary information about VA-CRAFT's effectiveness.

NCT ID: NCT01663337 Active, not recruiting - PTSD Clinical Trials

Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD

Start date: March 2013
Phase: N/A
Study type: Interventional

The broad, long-term objective of the current research is to improve treatment outcomes for individuals with comorbid posttraumatic stress disorder (PTSD) and alcohol abuse and dependence (AUD). The purpose of which is to evaluate changes in both PTSD symptoms and alcohol use and cravings associated with Cognitive Processing Therapy (CPT) or Relapse Prevention (RP) treatment in individuals with PTSD/AUD, along with mediators and moderators of outcomes. The study will randomize 235 PTSD/AUD participants recruited from the VA and from the community to CPT, RP, or Interactive Voice Response (IVR) assessment only (AO). Those in the AO condition will be re-randomized after the treatment phase to either RP or CPT. Individuals will be assessed pretreatment, immediately post-treatment, 3-, 6-, 9-, and 12-months post-treatment and will monitor symptoms daily throughout treatment.

NCT ID: NCT01652430 Completed - PTSD Clinical Trials

Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

Start date: October 2010
Phase: N/A
Study type: Observational

This study plans to examine if symptoms of PTSD affect how Veterans who have served in combat think and react to certain information, and whether or not this has an influence on suicidal thoughts.

NCT ID: NCT01638741 Recruiting - Depression Clinical Trials

The Need for Rehabilitation and the Connection With Attachment Styles Among Patients With Gynaecological Cancer

Start date: September 2011
Phase: N/A
Study type: Observational

The purpose of this study is to provide new knowledge about: - Integration of rehabilitation in a highly specialized gynaecological department. - Development and testing of an individually adapted rehabilitation process. - Needs for rehabilitation among women with gynaecological cancer. - Connection between adult attachment style for women with gynaecological cancer and their quality of life, rehabilitation needs and symptoms of depression /PTSD.

NCT ID: NCT01637584 Active, not recruiting - PTSD Clinical Trials

Neurobiology of Sleep and Sleep Treatment Response in Returning Veterans

NOSSTIP
Start date: April 2010
Phase: N/A
Study type: Interventional

The overarching objectives of this study are: 1) To investigate the neurobiology of posttraumatic stress disorder (PTSD) during REM and NREM sleep relative to wakefulness; 2) To identify the neurobiological underpinnings of sleep treatment response to prazosin or placebo during wakefulness, REM sleep, and NREM sleep in OIF/OEF veterans with PTSD; and 3) To explore pre-treatment brain activity patterns during wakefulness, REM sleep, and NREM sleep that predict sleep treatment response. We will also explore the stability of the PET signal by comparing pre- and post-placebo changes in brain glucose metabolism in non-responders. For non-PTSD veterans, the stability of the PET signal will be evaluated in a subsample of 6 veterans without PTSD who will repeat the PET imaging procedures 8 weeks after the initial PET series. The overarching hypothesis is that PTSD is characterized by neurobiological alterations in the amygdala, mPFC, and brain centers involved in the regulation of NREM and REM sleep, and that these neurobiological changes are normalized with effective sleep treatment.

NCT ID: NCT01627548 Withdrawn - PTSD Clinical Trials

UCLA Couples Counseling for Combat Veterans

CCCV
Start date: January 2012
Phase: N/A
Study type: Interventional

A pilot intervention of an existing intervention adapted for the returning warfighter population: a couples treatment for PTSD, Structured Approach Therapy (SAT), which emphasizes reducing the PTSD avoidance/numbing symptoms that are corrosive in families.

NCT ID: NCT01625962 Completed - PTSD Clinical Trials

Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)

Start date: October 2011
Phase: N/A
Study type: Observational

This is a prospective, longitudinal cohort study to evaluate the associations between indices of brain structure and function (measured at baseline, as soon as possible after injury) and course of post-traumatic stress disorder (PTSD) symptoms. Subjects will be service members who have sustained mild traumatic brain injury (classified as either "impact-induced mTBI" or "blast-induced mTBI"; n = 100 completers) or an extracranial injury (ECI) with no evidence of traumatic brain injury (TBI) (n = 100 completers). Subjects will complete an assessment battery at baseline and 6 months later that includes (1) structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) derived from a 3-Tesla magnet; (2) event-related brain potentials (ERPs) derived from brain electrical activity; (3) neurocognitive tests; and (4) neurological soft signs (NSS). Specific indices of brain structure and function derived from these assessments are hypothesized to demonstrate a significant relationship with course of PTSD symptoms, which will be measured at baseline, 3 months, and 6 months.

NCT ID: NCT01620866 Completed - Bipolar Disorder Clinical Trials

A Eye Movement Desensitization Reprocessing (EMDR) Study in Bipolar Traumatized Patients

BET
Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this pilot study is whether Eye Movement Desensitization Reprocessing (EMDR), an approved psychotherapy in posttraumatic stress disorder, improves mood, functioning, quality of life, cognition and BDNF levels in subsyndromal bipolar patients with trauma.

NCT ID: NCT01601067 Completed - PTSD Clinical Trials

Integrated Alcohol Disorder and PTSD Treatment

Start date: January 21, 2013
Phase: Phase 2
Study type: Interventional

Comorbidity of alcohol use disorder (AD) and posttraumatic stress disorder (PTSD) is common. Currently available treatments often do not lead to sustained recovery from these disorders, possibly because they typically do not include exposure therapy which is considered best practice treatments for PTSD. This study compares exposure-based integrated treatment to integrated coping skills psychotherapy (a well disseminated practice) for comorbid AD and PTSD with the hypothesis that exposure therapy will allow those with PTSD to better sustain PTSD symptom reduction and reduction in alcohol use. The aim of this grant is to change common treatment practices for comorbid AD and PTSD by increasing the availability of evidence-based PTSD treatment for those with AD.

NCT ID: NCT01599624 Completed - Depression Clinical Trials

Stress Resilience Training System

SRTS
Start date: October 2012
Phase: N/A
Study type: Interventional

The Stress Resilience Training System (SRTS) program is a stress reduction and resilience building system that blends cognitive training to anticipate the effects of stress with advanced biofeedback to mitigate stress effects and aftereffects, using a game-based learning framework on an iPad platform. The proposed study will evaluate the effectiveness of the SRTS program at reducing perceived stress, PTSD symptoms, depression, anxiety, sleep quality, coping, attrition and class/operational performance among United States Navy service members.